Stroke with Internal Carotid Artery Stenosis
Arch Neurol 58:605-609, Tsiskaridze,A.,et al, 2001
Clinical Presentation of Left Atrial Cardiac Myxoma
Medicine 80:159-172, Pinede,L.,et al, 2001
Recommendations for the Management of Intracranial Arteriovenous Malformations
Stroke 32:1458-1471, Ogilvy,C.S.,et al, 2001
Acute Obstructive Hydrocephalus Heralding Neurocysticercosis
Conn Med 65:451-454, Finelli,P.F., 2001
Sterile Cerebrospinal Fluid Ascites and Chronic Peritonitis
NEJM 345:297-298, Longstreth,G.F. &Buckwalter,N.R., 2001
Cisternal Cysticercosis: A Diagnostic Problem--A Short Report
Neurol India 49:206-208, Bannur,U. &Rajshekhar V., 2001
Corpus Callosal Signal Changes in Patients with Obstructive Hydrocephalus After Ventriculoperitoneal Shunting
AJNR 22:158-162, Lane,J.I.,et al, 2001
Multiple Sclerosis and Magnetic Resonance Imaging
Arch Neurol 58:35-36, Racke,M.K.,et al, 2001
Factors Affecting Formation and Growth of Intracranial Aneurysms
Stroke 32:485-491, Juvela,S.,et al, 2001
Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001
Is Early Ischemic Lesion Volume on Diffusion-Weighted Imaging an Independent Predictor of Stroke Outcome?
Stroke 31:2597-2602, Thijs,V.N.,et al, 2000
Clinicopath Conf, Granulomatous and Lymphocytic Hypophysitis
NEJM 343:1399-1406, Case 34-2000, 2000
Cardiac Arrhythmias and Stroke
Stroke 31:2925-2929, Engstrom,G.,et al, 2000
Syncope
NEJM 343:1856-1862, Kapoor,W.N., 2000
Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000
Effect of intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography
Stroke 31:2912-2919, The National Institute of Neurological Disorders a, 2000
Combined Perfusion- and Diffusion-Weighted MR Imagng in Acute Ischemic Stroke Durng the 1st Week: A Longitudinal Study
Radiology 217:886-894, Karnoen,J.O.,et al, 2000
MR Imaging of the Cauda Equina in Hereditary Motor Sensory Neuropathies: Correlations with Sural Nerve Biopsy
AJNR 21:1793-1798,1779, Cellerini,M.,et al, 2000
Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000
Pituitary Enlargement in Patients with Intracranial Hypotension Syndrome
Neurol 55:1895-1897,1771, Alvarez-Linera,J.,et al, 2000
Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000
Desmin Myopathy, a Skeletal Myopathy with Cardiomyopathy Caused by Mutations in the Desmin Gene
NEJM 342:770-780, Dalakas,M.C.,et al, 2000
Progressive Necrotic Myelopathy
ArchNeurol 57:355-361, Katz,J.D. & Ropper,A.H., 2000
Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000
Cardiac Dysfunction in Neuromuscular Diseases
The Neurologist 6:67-82, Pourmand,R., 2000
Cranial MR Imaging of Osteopetrosis
AJNR 21:1110-1115, Cure,J.K.,et al, 2000
Anticoagulation for Chronic Atrial Fibrillation
JAMA 283:2901-2903, Stern,S.,et al, 2000
Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000
Atrial Fibrilation and the Risk of Cerebral White Matter Lesions
Neurol 54:1795-1801, de Leeuw,F.E.,et al, 2000
How Well Does the Oxfordshire Community Stroke Project Classification Predict the Site and Size of the Infarct on Brain Imaging
JNNP 68:558-562,547, Mead,G.E.,et al, 2000
Comparison of Diffusion-Weighted MRI and CT in Acute Stroke
Neurol 54:1557-1561,1548,1549,1552, Lansberg,M.G.,et al, 2000
Deterioration of Giant Cell Arteritis With Corticosteroid Therapy
Arch Neurol 57:581-584, Staunton,H.,et al, 2000
Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000
Misdiagnosis of Epilepsy: Many Seizure-Like Attacks Have a Cardiovascular Cause
J Am Coll Cardiol 36:181-184, Zaidi,A. et al, 2000
Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000
Detection of Early CT Signs of >1/3 Middle Cerebral Artery Infarctions
Stroke 31:1667-1671, Kalafut,M.A. et al, 2000
Atrial Fibrillation Associated with Sumatriptan
BMJ 321:275, Morgan,D.R. et al, 2000
Coexisting Causes of Ischemic Stroke
Arch Neurol 57:1139-1144,1113, Moncayo,J. et al, 2000
Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000
Three-year Survival and Functional Outcome of Patients With Idiopathic Adult Hydrocephalus Syndrome
Neurol 55:576-578, Malm,J. et al, 2000
Granulomatous Hypophysitis Due to Wegener's Granulomatosis
AJNR 21:1466-1469, Goyal,M. et al, 2000
Hydrocephalus Is a Determinant of Early Mortality in Putaminal Hemorrhage
Stroke 31:2157-2162, Phan,T.G. et al, 2000
Prediction of Malignant Middle Cerebral Artery Infarction by Diffusion-Weighted Imaging
Stroke 31:2175-2181, Oppenheim,C. et al, 2000
Neuroimaging in Deteriorating Patients with Cerebellar Infarcts and Mass Effect
Stroke 31:2062-2067, Koh,M.G. et al, 2000
Leukocytosis: Basics of Clinical Assessment
Am Fam Physician 62:, Abramson,N. &Melton,B., 2000
Dysthyroid Orbitopathy
Semin Neurol 20:43-54, Jacobson,D.M., 2000
Complications During Apnea Testing in the Determination of Brain Death: Predisposing Factors
Neurol 55:1045-1048, Goudreau,J.L.,et al, 2000
Toxoplasmosis Manifesting as Hydroephalus on Computed Tomography
Infect Dis Clin Practice 9:390-392, Finelli,P.F. &Uphoff,D.F., 2000
Hypertrophic Olivary Degeneration: Metaanalysis of the Temporal Evolution of MR Findings
AJNR 21:1073-1077, Goyal, M.,et al, 2000